pH-Sensitive Polyketal Particles for Targeted Vaccine Delivery
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current vaccine delivery systems face challenges in efficiently targeting antigen-presenting cells and inducing optimal immune responses, particularly due to the limitations of existing adjuvants and delivery vehicles that are not pH-sensitive, leading to suboptimal immune modulation and potential toxicity.
Innovation Solution
Development of biodegradable polyketal particles and micelles that can encapsulate active agents, such as vaccines and immune modulatory agents, which undergo controlled degradation in acidic environments, allowing for targeted delivery and release within phagosomes, thereby enhancing immune activation and minimizing toxicity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional adjuvants and delivery vehicles are used, then immune activation is achieved, but toxicity increases and targeting efficiency decreases
Solution Approach 1:
The patent employs pH-sensitive polymers that change their degradation rate based on pH conditions. These polymers remain stable at physiological pH (7.4) but degrade rapidly in acidic environments (pH 5.0-6.5) of endosomes and lysosomes, enabling controlled release of adjuvants and antigens only after cellular uptake, thereby reducing systemic toxicity while maintaining immune activation efficacy
Solution Approach 2:
The patent introduces pH-sensitive polymeric particles as intermediary carriers between the adjuvant/antigen and the immune system. These particles protect the encapsulated agents during circulation, facilitate targeted delivery to antigen-presenting cells via endocytosis, and then degrade in the acidic endosomal compartment to release the payload, thus mediating between the therapeutic agent and the immune system while minimizing off-target effects
2Quantity of substance
If conventional delivery systems are used, then antigen delivery is achieved, but targeting precision to antigen-presenting cells decreases
Solution Approach 1:
The patent creates particles with differentiated local properties: a hydrophobic core for antigen encapsulation, a pH-sensitive polymer shell for environmental responsiveness, and surface modifications for cellular recognition. The particles exhibit stable properties during circulation but undergo localized degradation in the acidic endosomal compartment, enabling precise spatiotemporal control of antigen release specifically within antigen-presenting cells
Solution Approach 2:
The patent employs dynamic pH-sensitive polymers that transition from a stable, non-degradable state at physiological pH to a rapidly degrading state in acidic environments. This dynamic behavior allows the particles to maintain structural integrity during circulation and cellular uptake, then dynamically release their cargo once inside the endosomal compartment of antigen-presenting cells, achieving precise temporal and spatial control
3Ease of manufacture
If non-pH-sensitive particles are used, then manufacturing simplicity is maintained, but controlled release and targeting capability are reduced
Solution Approach 1:
The patent employs composite polymeric particles combining hydrophobic segments for antigen encapsulation with pH-sensitive polymer segments for environmental responsiveness. This composite structure integrates multiple functions (protection, targeting, controlled release) into a single particle system that can be manufactured using established emulsion or nanoprecipitation techniques, balancing manufacturing feasibility with advanced functionality
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The polyketal particles and micelles provide a controlled and efficient delivery of active agents, promoting optimal immune responses by targeting antigen-presenting cells and avoiding acidic degradation products, thus enhancing the effectiveness of vaccines and immune modulation.
Implementation Method 1
biodegradable particles comprising the polyketal polymers... undergo controlled degradation in acidic environments
Data Source
AI summary
The present invention provides biodegradable particles (e.g., three-dimensional particles) and micelles which can be used to encapsulate active agents for delivering to a subject. The present invention further provides methods for producing and delivering such particles and micelles. Additionally, the invention provides vaccination strategies that encompass the use of the novel particles and micelles.